Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Pharmacotherapy|December 29, 2017
Cabozantinib: A Multitargeted Oral Tyrosine Kinase InhibitorJordan N Markowitz, Karen M FancherCancer Chemotherapy and Pharmacology|September 17, 2020
Drug interactions with Bruton's tyrosine kinase inhibitors: clinical implications and managementKaren M Fancher, Jeremy J PappacenaJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 29, 2019
Moxetumomab pasudotox: A first-in-class treatment for hairy cell leukemiaKaren M Fancher, Zachary C Lally-MontgomeryAmerican Journal of Clinical Oncology|December 20, 2013
Off-Target Effects of BCR-ABL and JAK2 InhibitorsMyke R Green, Michael D Newton, Karen M FancherJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 20, 2015
Comparison of two different formulas for body surface area in adults at extremes of height and weightKaren M Fancher, Alicia J Sacco, Robert C Gwin, et al.Pageof 1